- Chelsea considers Artem Dovbyk as an alternative striker target amidst uncertainties with their current attacking lineup and Osimhen pursuit
- Dovbyk’s impressive performance in La Liga, with 16 goals for Girona, catches Chelsea’s attention as they monitor his progress
Chelsea have set their sights on Girona striker Artem Dovbyk as a potential alternative to Napoli’s Victor Osimhen.
The Blues, unsatisfied with their current attacking lineup, are rumoured to be actively seeking reinforcements this summer.
Nicolas Jackson’s debut season at Chelsea has been marked by inconsistency, managing to net 12 goals in 34 competitive outings.
Meanwhile, Armando Broja finds himself loaned out to Fulham, and his future at Stamford Bridge is uncertain. Young Brazilian talent Deivid Washington has seen limited action, making only two appearances this season.
Christopher Nkunku, though versatile, has grappled with injury woes throughout his maiden Premier League campaign.
While Osimhen remains Chelsea’s primary target, Paris Saint-Germain reportedly holds the upper hand in securing his signature for the upcoming 2024-25 season.
Amidst the competition for Osimhen’s signature, reports suggest that Chelsea are exploring Dovbyk as a viable alternative.
Scouts have closely monitored Dovbyk’s performances over the past year, prompting Chelsea to include him in their shortlist.
The 25-year-old has impressed in La Liga since his move from Ukrainian side Dnipro, notching 16 goals in 28 league appearances for Girona.
His contributions have been instrumental in Girona’s push for Champions League qualification, highlighted by a recent brace against Real Betis, breaking a seven-game goal drought.
Dovbyk’s impressive form has propelled him into contention for the Pichichi award, currently tied with Real Madrid’s Jude Bellingham and Osasuna’s Ante Budimir.
With Girona set to face Atletico Madrid on April 13, Dovbyk will have another opportunity to showcase his goal-scoring prowess, potentially furthering Chelsea’s interest in the talented striker.